Keith Sutton

Company: Resolution Therapeutics

Job title: Director of Preclinical Development

Seminars:

PANEL DISCUSSION: Leveraging Different Innate Cell Types for Therapeutic Efficacy in Oncology & Beyond 3:00 pm

With significant work taking place to understand the potential of novel innate cell types such as macrophages, neutrophils and iNKT cells for treatment applications in Oncology, attention also turns to the therapeutic application of innate cells for other important diseases such as inflammatory, autoimmune and fibrosis indications. This panel discussion will cover: Understanding the key…Read more

day: Conference Day Two

Exploiting the Phenotypic Plasticity of Macrophages in Disease Indications Outside Oncology 2:30 pm

Using macrophages to reprogramme the inflammatory niche Targeting of macrophage therapies Engineering the macrophage phenotype; getting from autologous to allogeneicRead more

day: Conference Day Two

Delving into the Cellular Biology of the Innate Immune System to Understand the Benefits and Drawbacks of Innate Cell Types & their Therapeutic Potential 1:00 pm

Recently, the innate cell therapy community has been looking beyond NK cells to help achieve persistence following therapeutic application. Despite these exciting developments, significant questions remain around the most appropriate way to harness the therapeutic potential of innate cells in both oncology and non-oncology indications: Join this workshop for insights into: Autologous vs allogeneic drug…Read more

day: Pre-Conference Day